
Shares of the Bayer BAYGn.DE rise 7% after the U.S. Supreme Court granted a hearing to the German life sciences company
A local trader points to developments in the Roundup weed killer lawsuits Bayer faces
The US Supreme Court agreed to hear Bayer's bid to curb cases claiming that Roundup causes cancer
Bayer expects a decision on merits by June 2026, the trader says
The stock is up 20% year-to-date and is on a 27-month high